Article | March 23, 2023

'Pivotal Time For CROs': ICON CEO Cutler On Changing APAC Trial Trends

Source: Citeline
GettyImages-1264666749 doctor

Dublin, Ireland-based ICON PLC witnessed a significant paradigm shift in clinical trials during the COVID-19 pandemic. Noted to be one of the top five contract research organizations in the world, CEO Steve Cutler recently pointed out a larger opportunity in decentralized trials that has the potential to be a “game changer” in the global pharma industry over the next five years.

In an interview, Cutler also refers to the need to accept new technologies by both clinical trial sites and regulators.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader